Suna | Tirzeptide allurar allura |
M | 99% |
Bayyanawa | Farin Cikin Fari |
Gwamnati | Allurar allura |
Gimra | 10mg, 15mg, 20mg, 30mg |
Ruwa | 3.0% |
Fa'idodi | Lura da ciwon sukari, inganta ikon sukari na jini |
Tirzeptaitide wani labari ne na glucose / gluctopple / glc-1) Cikakken juzu'i da kiba da kiba-gyaran giya marasa grauhepatitis. Lokaci na 3 ya wuce shirin gwaji na gwaji na 1-5 don tantance Tirzeptaptide, a duk faɗin munanan mutane da ke da nau'in ciwon sukari 2. Amfani da Tirzepata a cikin karatun asibiti yana da alaƙa da ragamar ragin glycated hemoglobin (-28%) da kuma nauyin jiki (-20) da kuma nauyin jiki (-20 zuwa -12.9 zuwa -12.9 triglycerides. An yarda da Tirzepatitide sosai, tare da ƙarancin haɗarin hypoglycaemia lokacin da aka yi amfani da insulin ko insulin asirce kuma ya nuna a gaba ɗaya bayanin kula mai rikice-rikice zuwa aji na Glp-1. Dangane da cewa, hujja daga wadannan fitokin na asibiti sun nuna cewa Tirzeptaide yana ba da sabuwar dama don ingancin rage hemoglobin da manya a cikin manya tare da nau'in ciwon sukari 2.